Abstract
We have studied the effects of growth factors and cytokines on the tumorigenicity and invasion capacity of tumor cells by using regressor and progressor tumor cell lines (ER‐1 and ERpP, respectively) derived from an SHR rat mammary adenocarcinoma. ER‐1 cells regress spontaneously whereas ERpP cells show invasive growth and high metastasis to lung and other organs in syngeneic SHR rats. When ER‐1 cells were pretreated with either epidermal growth factor (EGF) or transforming growth factor‐β (TGF‐β) for 24 h in vitro, and intraperitoneally transplanted into SHR rats, they grew and killed the host, whereas ER‐1 cells pretreated with tumor necrosis factor‐α did not. Tumorigenicity and invasion capacity of ERpP cells were also enhanced by treatment with EGF and TGF‐β. The ER‐1 cells pretreated with EGF, once grown in vivo, had acquired irreversible tumorigenicity and invasion capacity without requiring further EGF treatment, and the enhanced malignancy was irreversible. These findings suggest that growth factors play an important role in acquisition of malignancy of tumor cells.
Keywords: Rat mammary tumor, Tumorigenicity, Invasion and metastasis, Regressor tumor cell, Growth factor
Full Text
The Full Text of this article is available as a PDF (287.5 KB).
REFERENCES
- 1. ) Nowell , P. C.Mechanisms of tumor progression . Cancer Res. , 46 , 2203 – 2207 ( 1986. ). [PubMed] [Google Scholar]
- 2. ) Wei , W. and Heppner , G. H.Tumor infiltrating lymphocytes of spontaneous versus transplanted mouse mammary tumors . Cancer Immunol. Immunother. , 26 , 257 – 262 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. ) Rice , G. E. , Gimbrone , M. A. and Bevilacqua , M. P.Tumor cell‐endothelial interaction . Am. J. Pathol. , 133 , 204 – 211 ( 1988. ). [PMC free article] [PubMed] [Google Scholar]
- 4. ) Breillout , F. , Antoine , E. , Lascaux , V. , Rolland , Y. and Poupon , M. F.Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factor . J. Natl. Cancer Inst. , 81 , 702 – 705 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Mukai , M. , Shinkai , K. , Komatsu , K. and Akedo , H.Potentiation of invasive capacity of rat ascites hepatoma cells by transforming growth factor‐β . Jpn. J. Cancer Res. , 80 , 107 – 110 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. ) Dabbous , M. K. , North , S. M. , Haney , L. and Nicolson , G. L.Macrophage and lymphocyte potentiation of syngeneic tumor cell and host fibroblast collagenolytic activity in rats . Cancer Res. , 48 , 6832 – 6836 ( 1988. ). [PubMed] [Google Scholar]
- 7. ) Assoian , R. K. , Komoriya , A. , Meyers , C. A. , Miller , D. M. and Sporn , M. B.Transforming growth factor‐β in human platelets . J. Biol. Chem. , 258 , 7155 – 7160 ( 1983. ). [PubMed] [Google Scholar]
- 8. ) Singletary , S. E. , Baker , F. L. and Spitzer , E.Biological effect of epidermal growth factor on the in vitro growth of human tumors . Cancer , 47 , 403 ( 1987. ). [PubMed] [Google Scholar]
- 9. ) Kobayashi , H.Modification of the tumor cells: regression and progression of tumor cells by the administration of viruses and chemicals . Int., Cong. Series Excerpta Med. , 738 , 277 – 295 ( 1985. ). [Google Scholar]
- 10. ) Ishikawa , M. , Okada , F. , Hamada , J. and Kobayashi , H.Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5‐azacytidine . Int. J. Cancer , 39 , 338 – 342 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Hamada , J. , Takeichi , N. and Kobayashi , H.Inverse correlation between the metastatic capacity of cell clones derived from a rat mammary carcinoma and their intercellular communication with normal fibroblasts . Jpn. J. Cancer Res. , 78 , 1175 – 1178 ( 1987. ). [PubMed] [Google Scholar]
- 12. ) Akedo , H. , Shinkai , K. , Mukai , M. , Mori , Y. , Tateishi , R. , Tanaka , K. , Yamamoto , R. and Morishita , T.Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion . Cancer Res. , 46 , 2416 – 2422 ( 1986. ). [PubMed] [Google Scholar]
- 13. ) Hamada , J. , Takeichi , N. , Okada , F. , Ren , J. , Li , X. , Hosokawa , M. and Kobayashi , H.Progression of weakly malignant clone cells derived from rat mammary carcinoma by host cells reactive to plastic plates . Jpn. J. Cancer Res. , 83 , 483 – 490 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. ) Ren , J. , Hamada , J. , Okada , F. , Takeichi , N. , Morikawa , K. , Hosokawa , M. and Kobayashi , H.Correlation between the presence of microvilli and the growth or metastatic potential of tumor cells . Jpn. J. Cancer Res. , 81 , 920 – 926 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ) Rodeck , U. , Herlyn , M. and Menssen , H. D.Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors . Int. J. Cancer , 40 , 687 – 690 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Pilot , H. C.Progression: the terminal stage in carcinogenesis . Jpn. J. Cancer Res. , 80 , 599 – 607 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. ) Heim , S. , Mandahl , N. and Mitelman , F.Genetic convergence and divergence in tumor progression . Cancer Res. , 48 , 5911 – 5916 ( 1988. ). [PubMed] [Google Scholar]
- 18. ) Frost , P. , Kerbel , R. S. , Baver , E. , Tartamella , B. R. and Celalu , W.Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors . Cancer Res. , 43 , 125 – 132 ( 1983. ). [PubMed] [Google Scholar]
- 19. ) Poupon , M. F. , Pauwels , C. , Jasmin , C. , Antoine , E. , Lascaux , V. and Rosa , B.Amplified pulmonary metastasis of a rat rhabdomyosarcoma in response to nitrosourea treatment . Cancer Treat. Rep. , 68 , 749 – 754 ( 1984. ). [PubMed] [Google Scholar]
- 20. ) Kerbel , R. S. , Frost , P. , Liteplo , R. , Carlow , D. A. and Elliott , B. E.Possible epigenetic mechanisms of tumor progression: induction of high‐frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic property of tumor cell populations by 5‐azacytidine treatment . J. Cell. Physiol. , 3 , 87 – 97 ( 1984. ). [DOI] [PubMed] [Google Scholar]